These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3148785

  • 1. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
    Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J.
    Klin Wochenschr; 1988 Oct 17; 66(20):1019-23. PubMed ID: 3148785
    [Abstract] [Full Text] [Related]

  • 2. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 17; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 3. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Dec 17; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 4. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).
    Mohácsi G, Magori A, Sonkodi S.
    Int Urol Nephrol; 1988 Sep 01; 20(3):315-25. PubMed ID: 3403200
    [Abstract] [Full Text] [Related]

  • 6. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 01; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 May 01; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 8. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
    Bitencourt Dias C, Pinheiro CC, Malafronte P, Titan S, Alves de Brito G, Gera Abrão J, Dos Santos Silva V, Toledo Barros R, Woronik V.
    Clin Nephrol; 2011 Jul 01; 76(1):57-63. PubMed ID: 21722606
    [Abstract] [Full Text] [Related]

  • 9. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
    Jindal K, West M, Bear R, Goldstein M.
    Am J Kidney Dis; 1992 Jan 01; 19(1):61-7. PubMed ID: 1739084
    [Abstract] [Full Text] [Related]

  • 10. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA, Rovin BH, Agarwal AK, Spetie DN.
    Am J Kidney Dis; 2005 Apr 01; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract] [Full Text] [Related]

  • 11. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb 01; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 12. Management of the nephrotic syndrome.
    Linshaw MA, Gruskin AB.
    Clin Pediatr (Phila); 1974 Jan 01; 13(1):45-51. PubMed ID: 4588668
    [No Abstract] [Full Text] [Related]

  • 13. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
    Branten AJ, Reichert LJ, Koene RA, Wetzels JF.
    QJM; 1998 May 01; 91(5):359-66. PubMed ID: 9709470
    [Abstract] [Full Text] [Related]

  • 14. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec 01; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 01; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 16. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.
    Kidney Int; 2002 Jan 01; 61(1):219-27. PubMed ID: 11786104
    [Abstract] [Full Text] [Related]

  • 17. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 Jan 01; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 18. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 27; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 20. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
    Gigante A, Rosato E, Liberatori M, Gasperini ML, Giannakakis K, Barbano B, Cianci R, Salsano F, Amoroso A.
    J Biol Regul Homeost Agents; 2012 Aug 27; 26(1):135-8. PubMed ID: 22475105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.